JFL Life Sciences Balance Sheet Health
Financial Health criteria checks 6/6
JFL Life Sciences has a total shareholder equity of ₹355.8M and total debt of ₹56.9M, which brings its debt-to-equity ratio to 16%. Its total assets and total liabilities are ₹566.4M and ₹210.6M respectively. JFL Life Sciences's EBIT is ₹41.2M making its interest coverage ratio 5. It has cash and short-term investments of ₹300.0K.
Key information
16.0%
Debt to equity ratio
₹56.90m
Debt
| Interest coverage ratio | 5x |
| Cash | ₹300.00k |
| Equity | ₹355.80m |
| Total liabilities | ₹210.60m |
| Total assets | ₹566.40m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: JFLLIFE's short term assets (₹431.3M) exceed its short term liabilities (₹199.8M).
Long Term Liabilities: JFLLIFE's short term assets (₹431.3M) exceed its long term liabilities (₹10.8M).
Debt to Equity History and Analysis
Debt Level: JFLLIFE's net debt to equity ratio (15.9%) is considered satisfactory.
Reducing Debt: JFLLIFE's debt to equity ratio has reduced from 167.6% to 16% over the past 5 years.
Debt Coverage: JFLLIFE's debt is well covered by operating cash flow (146.9%).
Interest Coverage: JFLLIFE's interest payments on its debt are well covered by EBIT (5x coverage).